Filing Details
- Accession Number:
- 0001493152-21-004598
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-23 16:14:37
- Reporting Period:
- 2021-02-19
- Accepted Time:
- 2021-02-23 16:14:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318306 | Abeona Therapeutics Inc. | ABEO | Pharmaceutical Preparations (2834) | 830221517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744816 | Elliot Paul Mann | 1330 Avenue Of The Americas, 33Rd Floor New York NY 10019 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-19 | 45,566 | $1.28 | 45,566 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-19 | 45,566 | $2.38 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-02-19 | 45,566 | $0.00 | 45,566 | $1.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-17 | 2030-06-17 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.34 to $2.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
